Andreas Emmenegger

Andreas Emmenegger was the founder of PIQUR Therapeutics AG, founded in 2011, and served as Member-Supervisory Board from 2011 to 2018.
Mr. Emmenegger is also the founder of Targimmune Therapeutics AG.
Current positions include Member-Supervisory Board at Luzerner Kantonalbank AG since 2016, Member-Management Board at Molecular Partners, Inc., Chief Financial Officer at Owkin Switzerland SARL, and Chief Financial & Business Officer at Swiss Rockets AG.
Former positions include Head-Strategic Alliance Finance at F.
Hoffmann-La Roche Ltd. from 2006 to 2007, Chief Financial Officer at Interroll Holding AG from 1997 to 2000, Chief Financial Officer at The Fantastic Co. AG from 2000 to 2003, Chief Financial Officer at Roche Glycart AG from 2005 to 2006, Chief Financial Officer at Molecular Partners AG from 2006 to 2022, Controller at Dräger Beteiligungen AG from 1992 to 1996, and Principal at Roche Holding AG.
Education includes undergraduate studies at Lucerne University of Applied Sciences & Arts and undergraduate and MBA degrees at Instituto de Estudios Superiores de la Empresa.